Detection and Imaging of Active Substances in Early Atherosclerotic Lesions using Fluorescent Probes

Atherosclerosis (AS) is a vascular disease caused by chronic inflammation and lipids, which is the main cause of myocardial infarction, stroke and other cardiovascular diseases. Atherosclerosis is often difficult to detect in early stages due to the absence of clinically significant vascular stenosis. This is not conducive to the early intervention and treatment of the disease. Over the past decade, researchers have developed various imaging methods for the detection and imaging of atherosclerosis. At the same time, more and more biomarkers are being found that can be used as targets for detecting atherosclerosis. Therefore, the development of a variety of imaging methods and a variety of targeted imaging probes is an important project to achieve early assessment and treatment of atherosclerosis. This paper provides a comprehensive review of the optical probes used to detect and target atherosclerosis imaging in recent years, and describes the current challenges and future development directions.